PELAX
Price
$6.21
Change
-$0.01 (-0.16%)
Updated
Sep 9 closing price
Net Assets
2.4B
VSHEX
Price
$8.97
Change
-$0.01 (-0.11%)
Updated
Sep 9 closing price
Net Assets
21.97M
Interact to see
Advertisement

PELAX vs VSHEX

Header iconPELAX vs VSHEX Comparison
Open Charts PELAX vs VSHEXBanner chart's image
PIMCO Emerging Mkts Lcl Ccy and Bd A
Price$6.21
Change-$0.01 (-0.16%)
VolumeN/A
Net Assets2.4B
Virtus Stone Harbor Local Markets A
Price$8.97
Change-$0.01 (-0.11%)
VolumeN/A
Net Assets21.97M
PELAX vs VSHEX Comparison Chart in %
Loading...
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PELAX has more cash in the bank: 2.4B vs. VSHEX (22M). PELAX pays higher dividends than VSHEX: PELAX (6.52) vs VSHEX (0.00). PELAX was incepted earlier than VSHEX: PELAX (18 years) vs VSHEX (3 years). PELAX (2.00) is less costly to investors than VSHEX (1.90). PELAX is a more actively managed with annual turnover of: 135.00 vs. VSHEX (78.00). PELAX (4%) and VSHEX (4%) have equivalent initial investment costs. PELAX has a lower initial minimum investment than VSHEX: PELAX (1000) vs VSHEX (2500). PELAX annual gain was more profitable for investors over the last year : 12.73 vs. VSHEX (7.16).
PELAXVSHEXPELAX / VSHEX
Total Expense Ratio2.001.25160%
Annual Report Gross Expense Ratio2.001.90105%
Fund Existence18 years3 years-
Gain YTD16.61314.541114%
Front Load4%4%100%
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets2.4B22M10,918%
Annual Yield % from dividends6.520.00-
Returns for 1 year12.737.16178%
Returns for 3 years38.6122.18174%
Returns for 5 years23.75N/A-
Returns for 10 years54.14N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CREEX9.74N/A
N/A
Columbia Real Estate Equity Inst
ANODX25.24N/A
N/A
American Century Small Cap Growth R6
BISRX26.30N/A
N/A
Brandes International Small Cap EquityR6
OFAVX27.80N/A
N/A
Olstein All Cap Value A
EEMRX9.41N/A
N/A
MFS Emerging Markets Equity Research C